Measuring bone marrow cellularity is typically done using a biopsy of the iliac crest, but a recent study published in the Journal of Nuclear Medicine indicates that MRI images may also adequately, and noninvasively, measure in vivo bone marrow cellularity.

iCAD has received a letter from The Nasdaq Stock Market stating that for the previous 30 consecutive business days, the bid price of the companys common stock closed below the minimum $1.00 per share requirement for continued inclusion on The Nasdaq Global Market.

The University of Virginia (UVA) Center for Telehealth in Charlottesville, was awarded a nearly $1 million grant from the U.S. Health Resources and Services Administration to create the Mid-Atlantic Telehealth Resource Center. UVA, in partnership with telehealth networks across the region, will link rural and urban healthcare providers to expand telehealth capabilities.

Konica Minolta Medical Imaging's Aero DR Wireless system has received clearance from Health Canada, making the system available for sale in Canada.

GE Hitachi Nuclear Energy (GEH) and Exelon are partnering to study the feasibility of producing molybdenum-99 (Mo-99), the most commonly used medical isotope, at Clinton Power Station, a nuclear power plant in Clinton, Ill.

Healthcare spending in the U.S. reached $2.6 trillion in 2010, however, only 5.5 percent, or $140.5 billion, of that was spent on evaluating new treatment options and research, according to a Sept. 8 report put forth by Research! America.

Proton irradiation can preserve some vision and prevent eye removal in patients with tumors adjacent to the optic disc, according to a study published online Sept. 13 in Archives of Ophthalmology.

Dalcetrapib (Roche) modulates cholesteryl ester transfer protein activity; however, the dal-PLAQUE study published online Sept. 12 in the Lancet, showed no evidence of a pathological effect related to the arterial wall over 24 months duration. While the trial found that dalcetrapib may have long standing vascular effects, including a reduction in vessel enlargement over 24 months, researchers said that more data are necessary to understand the long-term safety of the molecule.